Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Advaxis Inc.

TRADE

NASDAQ: ADXSHealthcare / Biotechnology / USA
1.44+0.01+0.70%Vol 141 0081Y Perf -76.23%
Aug 16th, 2018 16:00
BID1.42 ASK1.44
Open1.43 Previous Close1.43
Pre-Market- After-Trading1.42
 - -%  -0.02 -1.39%
Target Price
2.50 
Analyst Rating
Moderate Buy 2.00
Potencial %
73.61 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)76 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
4.60 
Earnings Date
10th Sep 2018

Today's Price Range

1.401.47

 

52wk Range

1.157.45

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
2.13%
3 Months
-18.64%
6 Months
-42.63%
1 Year
-76.23%
3 Years
-91.47%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ADXS1.440.01000.70
AAPL213.323.08001.46
GOOG1 206.49-7.8900-0.65
MSFT107.64-0.0200-0.02
XOM78.001.06001.38
WFC58.660.67001.16
JNJ132.482.05001.57
FB174.70-4.8300-2.69
GE12.300.08000.65
JPM114.771.07000.94
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.10
Current Ratio 3.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-1 099.80
EBITDA Margin-1 084.00
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.68
PS Ratios 13.71
Price to Cash Flow -
Price to Free Cash Flow -1.50
Cash Flow Per Share -1.71
Price to Tangible Book1.90
Book Value per Share0.86
Enterprise Value (in ths.)18 436
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-84.35
ROE last 12 Months -130.76
Return on Assets (5Y Avg) -46.27
ROA last 12 Months -82.73
Return on Capital (5Y Avg) -117.03
ROC last 12 Months -131.63
Return on invested Capital Q -31.99
Return on invested Capital Y-108.41
Assets Turnover0.00
Receivables Turnover1.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)5 566
Revenue per Share 0.11
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.41-0.2734.15
Q01 2018-0.58-0.4915.52
Q04 2017-0.55-0.57-3.64
Q03 2017-0.56-0.80-42.86
Q02 2017-0.49-0.51-4.08
Q01 2017-0.52-0.4317.31
Q03 2016-0.22-0.48-118.18
Q02 2016-0.52-0.4513.46
Earnings Per EndEstimateRevision %Trend
7/2018 QR-0.4125.45Positive
10/2018 QR-0.3430.61Positive
10/2018 FY-1.7326.69Positive
10/2019 FY-1.4839.34Positive
Next Report Date10th Sep 2018
Estimated EPS Next Report-0.25
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume141 008
Shares Outstanding (in ths.)52 620
Trades Count360
Dollar Volume195 498
Avg. Volume848 103
Avg. Weekly Volume198 573
Avg. Monthly Volume346 198
Avg. Quarterly Volume720 835

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

65%35%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Strong Buy
1.00

There are no comments yet.

News

x